Compare MCHP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHP | EW |
|---|---|---|
| Founded | 1989 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3B | 50.2B |
| IPO Year | 2004 | 1999 |
| Metric | MCHP | EW |
|---|---|---|
| Price | $96.96 | $87.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 21 |
| Target Price | $85.59 | ★ $96.37 |
| AVG Volume (30 Days) | ★ 10.1M | 4.5M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 2300.00 | N/A |
| EPS | 0.22 | ★ 0.66 |
| Revenue | $5,349,500,000.00 | ★ $6,067,600,000.00 |
| Revenue This Year | $8.12 | $13.39 |
| Revenue Next Year | $22.55 | $9.81 |
| P/E Ratio | $416.00 | ★ $133.58 |
| Revenue Growth | ★ 34.38 | 11.55 |
| 52 Week Low | $48.52 | $72.30 |
| 52 Week High | $105.91 | $89.14 |
| Indicator | MCHP | EW |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 62.88 |
| Support Level | $61.76 | $80.91 |
| Resistance Level | $105.91 | N/A |
| Average True Range (ATR) | 3.90 | 2.34 |
| MACD | -0.94 | 0.53 |
| Stochastic Oscillator | 62.31 | 84.61 |
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.